The global human identification market revenue was around US$ 1.5 billion in 2022 and is estimated to reach US$ 3.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.3% during the forecast period from 2023 to 2031.
Human identification is the scientific field that deals with the identification and verification of people via the use of various biometric systems and technologies. This technique is focused on identifying ridges on the suspect's fingers because each person has different ridge forms and classifications. It is mostly utilized in forensic laboratories for blood analysis, Deoxyribonucleic acid (DNA), hair, teeth, and skin.
Market Driving Factors
The surge in demand for lowering the cost and time of DNA analysis drives the market growth. The deoxyribonucleic acid has significantly cutting-edge criminal justice over the last decade. When biological evidence is available, DNA can be utilised to determine criminals with incredible accuracy. In addition, DNA technology is becoming increasingly important in ensuring the fairness and accuracy of the criminal judicial system. As a result, it surges demand for decreasing the cost and time of DNA analysis.
Funding from both government and private organizations has increased significantly in the human identification business, which has been a major driving factor for the market expansion. In addition, governments across the world have also recognized the vital importance of human identification systems in assuring public safety, national security, and efficient service delivery. As a result, governments are actively funding the development and implementation of cutting-edge identification technologies.
The high cost of genomic instruments and the shortage of trained and skilled professionals are estimated to hamper the market growth.
Regional Analysis
North America dominates the market during the forecast period. This is due to the existence of the primary key players, the increase of funds from private and government organizations, the surge in support for forensics development, and technological advancements for forensic science in the region.
Segmentation Insights
Product Insight
The assay kits & reagents segment dominates the market. This is because increase in applications of assay kits and reagents for paternity testing and forensic analysis, and the rise in the adoption of DNA-based diagnostics. Therefore, this factor boosts the segment growth.
Technology Insight
The polymerase chain reaction (PCR) segment dominates the market during the forecast period. The polymerase chain reaction is a laboratory method for rapidly producing (amplifying) millions to billions of copies of a single DNA segment, which may later be examined in more depth for various applications, such as paternity testing, DNA profiling for forensics, and other applications. PCR is utilised globally in laboratories because of its easy procedure and instrument availability.
End User Insight
The forensic laboratories segment dominated the market and is expected to maintain its dominance. This can be attributed to the surge in the number of forensic laboratories as well as the advancement in forensic laboratories to examine evidence collected from crime locations.
Prominent Companies
Segmentation Outline
The global human identification market segmentation focuses on Product, Technology, Application, End User, and Region.
By Product
By Technology
By Application
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL HUMAN IDENTIFICATION MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: HUMAN IDENTIFICATION MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL HUMAN IDENTIFICATION MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL HUMAN IDENTIFICATION MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 INSTRUMENTS
5.3 ASSAY KITS AND REAGENTS
5.4 SOFTWARE
6 GLOBAL HUMAN IDENTIFICATION MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 POLYMERASE CHAIN REACTION
6.3 NEXT-GENERATION SEQUENCING
6.4 CAPILLARY ELECTROPHORESIS
6.5 OTHERS
7 GLOBAL HUMAN IDENTIFICATION MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 FORENSIC APPLICATIONS
7.3 PATERNITY IDENTIFICATION
7.4 OTHERS
8 GLOBAL HUMAN IDENTIFICATION MARKET, BY END USER
8.1 OVERVIEW
8.2 FORENSIC LABORATORIES
8.3 RESEARCH CENTERS AND ACADEMIC AND GOVERNMENT INSTITUTES
9 GLOBAL HUMAN IDENTIFICATION MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3.1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL HUMAN IDENTIFICATION MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
10.4 COMPETITIVE DASHBOARD
10.5 PRODUCT MAPPING
10.6 TOP PLAYER POSITIONING, 2022
10.7 COMPETITIVE HEATMAP
10.8 TOP WINNING STRATEGIES
11 COMPANY PROFILES
11.1 PROMEGA CORPORATION
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.2 QIAGEN N.V
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.3 AUTOGEN INC
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.4 GENETEK BIOPHARMA GMBH
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.5 HAMILTON COMPANY
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.6 SECURIGENE TECHNOLOGIES INC
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.7 THERMO FISHER SCIENTIFIC INC
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.8. CAROLINA BIOLOGICAL SUPPLY COMPANY
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.9 BIO-RAD LABORATORIES INC
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
11.10 INNOGENOMICS TECHNOLOGIES
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved